Kalydeco slows CF disease progression over time, study finds
Treatment with Kalydeco (ivacaftor) for almost eight years consistently improved lung function and reduced mortality in people with cystic fibrosis...
Treatment with Kalydeco (ivacaftor) for almost eight years consistently improved lung function and reduced mortality in people with cystic fibrosis...
Opal Sandy, who was born completely deaf because of a rare genetic condition and can now hear ... unaided for...
For a while now, we have been seeing an increasing trend concerning levels of developmental delay in toddlers. At first,...